Indaptus raises $24.0M in private placement of 20.3M shares at Nasdaq minimum price plus $0.015

Indaptus Therapeutics, Inc.

Stock Purchase Agreement dated Sept 8, 2026; 20,338,974 shares for ~$24.0M gross proceeds.
Per-share price = Nasdaq Minimum Price (lower of prior-day close or 5-day average) + $0.015.
Proceeds for working capital, R&D, and potential neurotechnology sleep-device preclinical work.
Closing expected within 15 business days; resale registration statement to be filed post-closing.
Company has 133,242,324 shares outstanding; warrants for 1,788,729 shares at $19.57 weighted avg.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.